Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Slides:

Advertisements

Similar presentations

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Advertisements

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Thomas J. Birdas, MD, Richard P. M

Morbidity and Mortality of Major Pulmonary Resections in Patients With Early-Stage Lung Cancer: Initial Results of the Randomized, Prospective ACOSOG.

Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Randomized controlled trial of a special acupuncture technique for pain after thoracotomy Gary Deng, MD, PhD, Valerie Rusch, MD, Andrew Vickers, PhD,

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Anthony Lemaire, MD, William R

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Andrea S. Wolf, MD, MPH, Scott J

Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

Samuel P. Morreau, David A. Haydock, MBChB, FRACS

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Thomas J. Birdas, MD, Richard P. M

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer Stephen A. Barnett, MBBS, Robert.

Use of Amiodarone After Major Lung Resection

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Lobectomy improves ventilatory function in selected patients with severe COPD1 Robert J Korst, MD, Robert J Ginsberg, MD, Maneesh Ailawadi, MD, Manjit.

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Pulmonary Resection for Lung Cancer in Octogenarians

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Phillip G. Rowse, MD, Dawn E

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

PillCam in Gastric Conduit After Ivor Lewis Esophagectomy

Bernard J. Park, MD, Matthew Bacchetta, MD, Manjit S

Nael Martini: A Leader in Thoracic Surgical Oncology

Is there a role for pneumonectomy in pulmonary metastases?1

Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma Rebecca P. Petersen, MD, MSc, Steven.

Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience Hua Li, MD, PhD, Deming Xu,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Neoadjuvant and Adjuvant Chemotherapy in Resected Pulmonary Large Cell Neuroendocrine Carcinomas: A Single Institution Experience Inderpal S. Sarkaria,

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Raja M. Flores, MD, Bernard J

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Alexander H. Moskovitz, MD, Nabil P

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Michael J. Weyant, MD, Manjit S

Thirty-Day Mortality Underestimates the Risk of Early Death After Major Resections for Thoracic Malignancies Robert R. McMillan, MD, MPH, Alexandra Berger,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Prognostic Factors for Recurrence After Pulmonary Resection of Colorectal Cancer Metastases Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C. Haney, MD, Leonard Saltz, MD, Bernard Park, MD, Raja Flores, MD, Nabil Rizk, MD, Manjit S. Bains, MD, Joseph Dycoco, BS, Thomas A. D'Amico, MD, David H. Harpole, MD, Nancy Kemeny, MD, Valerie W. Rusch, MD, Robert Downey, MD The Annals of Thoracic Surgery Volume 87, Issue 6, Pages 1684-1688 (June 2009) DOI: 10.1016/j.athoracsur.2009.03.034 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Primary colorectal tumor resection information. Type of resection (A), stage (B), and nodal stage (C) of primary colorectal cancer patients included in the study. The Annals of Thoracic Surgery 2009 87, 1684-1688DOI: (10.1016/j.athoracsur.2009.03.034) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Chemotherapeutic agents administered to patients before (A) and after (B) pulmonary resection of colorectal metastases. (FU = 5-fluorouracil; Irino = irinotecan; LV = leucovorin; Oxal = oxaliplatin.) The Annals of Thoracic Surgery 2009 87, 1684-1688DOI: (10.1016/j.athoracsur.2009.03.034) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Extent of pulmonary resection of colorectal metastases. The Annals of Thoracic Surgery 2009 87, 1684-1688DOI: (10.1016/j.athoracsur.2009.03.034) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Lobes involved (A) and number of nodules resected (B) during pulmonary resection of colorectal metastases. The Annals of Thoracic Surgery 2009 87, 1684-1688DOI: (10.1016/j.athoracsur.2009.03.034) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Overall survival (A) and recurrence-free survival (B) among patients undergoing pulmonary resection for colorectal metastases. The Annals of Thoracic Surgery 2009 87, 1684-1688DOI: (10.1016/j.athoracsur.2009.03.034) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions